Next Article in Journal
Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFAlin-Modified Peptidic Radioligands Targeting Both Integrin αvβ3 and the MC1 Receptor—Suitable for the Specific Visualization of Melanomas?
Next Article in Special Issue
COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now–New Hopes?
Previous Article in Journal
Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species
Previous Article in Special Issue
Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor
Review

Article Versions Notes

Action Date Notes Link
article pdf uploaded. 7 June 2021 16:05 CEST Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/6/546/pdf
article pdf uploaded. 7 June 2021 16:11 CEST Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/6/546/pdf
article xml file uploaded 8 June 2021 05:28 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/6/546/xml
article xml uploaded. 8 June 2021 05:28 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/6/546/xml
article pdf uploaded. 8 June 2021 05:28 CEST Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/6/546/pdf
article html file updated 8 June 2021 05:30 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/6/546/html
article html file updated 8 June 2021 10:07 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1424-8247/14/6/546/html
Back to TopTop